相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MAMMALIAN TRANSIENT RECEPTOR POTENTIAL TRPA1 CHANNELS: FROM STRUCTURE TO DISEASE
Karel Talavera et al.
PHYSIOLOGICAL REVIEWS (2020)
Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators
Karl Messlinger et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Early Metazoan Origin and Multiple Losses of a Novel Clade of RIM Presynaptic Calcium Channel Scaffolding Protein Homologs
Thomas Piekut et al.
GENOME BIOLOGY AND EVOLUTION (2020)
Gap junctions, pannexins and pain
David C. Spray et al.
NEUROSCIENCE LETTERS (2019)
Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists
Jill C. Rau et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
CGRP and the Trigeminal System in Migraine
Smriti Iyengar et al.
HEADACHE (2019)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease
Evanthia Nanou et al.
NEURON (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke et al.
NEUROLOGY (2018)
Serum calcium and risk of migraine: a Mendelian randomization study
Peter Yin et al.
HUMAN MOLECULAR GENETICS (2017)
Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia
Lorena Travaglini et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
The genetic relationship between epilepsy and hemiplegic migraine
Yiqing Huang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons
Zachary L. Durham et al.
ARCHIVES OF ORAL BIOLOGY (2017)
Activity-Dependent Calcium, Oxygen, and Vascular Responses in a Mouse Model of Familial Hemiplegic Migraine Type 1
Lila Khennouf et al.
ANNALS OF NEUROLOGY (2016)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization
Paul L. Durham
CURRENT PAIN AND HEADACHE REPORTS (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
ELEVATED LEVELS OF CALCITONIN GENE-RELATED PEPTIDE IN UPPER SPINAL CORD PROMOTES SENSITIZATION OF PRIMARY TRIGEMINAL NOCICEPTIVE NEURONS
Lauren E. Cornelison et al.
NEUROSCIENCE (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine
Yuen H. Kwok et al.
JOURNAL OF PAIN RESEARCH (2016)
Recent advances in migraine therapy
Fabio Antonaci et al.
SPRINGERPLUS (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Hydrogen sulfide determines HNO-induced stimulation of trigeminal afferents
Vanessa Wild et al.
NEUROSCIENCE LETTERS (2015)
Gender influences headache characteristics with increasing age in migraine patients
Hayrunnisa Bolay et al.
CEPHALALGIA (2015)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Calcium channels and migraine
Daniela Pietrobon
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording
Jakob Moller Hansen et al.
BRAIN (2013)
The typical duration of migraine aura: A systematic review
Michele Viana et al.
CEPHALALGIA (2013)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies
Todd A. Smitherman et al.
HEADACHE (2013)
Cortical spreading depression and migraine
Andrew C. Charles et al.
NATURE REVIEWS NEUROLOGY (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura
Philip R. Holland et al.
ANNALS OF NEUROLOGY (2012)
P/Q-type calcium channel modulators
V. Nimmrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
Jan Hoffmann et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
Chronic migraine-classification, characteristics and treatment
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2012)
The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research
Wayne N. Burton et al.
MAYO CLINIC PROCEEDINGS (2012)
Activation of Central Trigeminovascular Neurons by Cortical Spreading Depression
XiChun Zhang et al.
ANNALS OF NEUROLOGY (2011)
New directions in migraine
Greg A. Weir et al.
BMC MEDICINE (2011)
Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor
Anne Dieterle et al.
CEPHALALGIA (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response
Tony W. Ho et al.
HEADACHE (2011)
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects
Alice De Corato et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline
T. Freilinger et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Calcitonin Gene-Related Peptide Promotes Cellular Changes in Trigeminal Neurons and Glia Implicated in Peripheral and Central Sensitization
Ryan J. Cady et al.
MOLECULAR PAIN (2011)
ROLE FOR VOLTAGE GATED CALCIUM CHANNELS IN CALCITONIN GENE-RELATED PEPTIDE RELEASE IN THE RAT TRIGEMINOVASCULAR SYSTEM
D. V. Amrutkar et al.
NEUROSCIENCE (2011)
TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation
Phillip Edward Kunkler et al.
PAIN (2011)
Increased Susceptibility to Cortical Spreading Depression in the Mouse Model of Familial Hemiplegic Migraine Type 2
Loredana Leo et al.
PLOS GENETICS (2011)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
CaV2.1 channelopathies
Daniela Pietrobon
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Genetic Calcium Signaling Abnormalities in the Central Nervous System: Seizures, Migraine, and Autism
J. Jay Gargus
YEAR IN HUMAN AND MEDICAL GENETICS 2009 (2009)
CaV2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations
Paul J. Adams et al.
CHANNELS (2009)
Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Roger K. Cady et al.
HEADACHE (2009)
Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing
R. W. Labrum et al.
JOURNAL OF MEDICAL GENETICS (2009)
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology
Alessandro Capuano et al.
MOLECULAR PAIN (2009)
Enhanced Excitatory Transmission at Cortical Synapses as the Basis for Facilitated Spreading Depression in Cav2.1 Knockin Migraine Mice
Angelita Tottene et al.
NEURON (2009)
The hemiplegic migraine-associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition
Selma A. Serra et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine
A. H. Stam et al.
CLINICAL GENETICS (2008)
Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation
Yee-Cheun Chan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Calcium channels, neuromuscular synaptic transmission and neurological diseases
Francisco J. Urbano et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Migraine: a genetic disease?
Pasquale Montagna
NEUROLOGICAL SCIENCES (2008)
Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype
Jakob Moller Hansen et al.
NEUROLOGY (2008)
The S218L familial hemiplegic migraine mutation promotes deinhibition of Cav2.1 calcium channels during direct G-protein regulation
Norbert Weiss et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine
B. de Vries et al.
NEUROLOGY (2007)
A tarantula peptide against pain via ASIC1a channels and opioid mechanisms
Michel Mazzuca et al.
NATURE NEUROSCIENCE (2007)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
Age and gender-dependent alternative splicing of P/Q-type calcium channel EF-hand
S. Y. Chang et al.
NEUROSCIENCE (2007)
Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal
MM Santafé et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons
EJ Bowen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine
M Dichgans et al.
LANCET (2005)
Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel
CF Barrett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Function and dysfunction of synaptic calcium channels: insights from mouse models
D Pietrobon
CURRENT OPINION IN NEUROBIOLOGY (2005)
Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma
A Tottene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack
G Juhasz et al.
CEPHALALGIA (2005)
Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission
YQ Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression
AMJM van den Maagdenberg et al.
NEURON (2004)
Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy
YQ Cao et al.
NEURON (2004)
Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating -: Evidence for β-subunit isoform-specific effects
C Müllner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation
EE Kors et al.
ARCHIVES OF NEUROLOGY (2003)
Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family
I Alonso et al.
ARCHIVES OF NEUROLOGY (2003)
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2
M De Fusco et al.
NATURE GENETICS (2003)
The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Cav2.1) calcium channels expressed in human embryonic kidney cells
K Melliti et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat
MM Santafe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons
A Tottene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine
G Terwindt et al.
ARCHIVES OF NEUROLOGY (2002)
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
H Bolay et al.
NATURE MEDICINE (2002)
Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients
P Sarchielli et al.
NEUROLOGY (2001)
The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.
A Ducros et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Delayed cerebral edema and fatal coma after minor head trauma: Role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine
EE Kors et al.
ANNALS OF NEUROLOGY (2001)
Acute effects of substance P and calcitonin gene-related peptide in human skin - A microdialysis study
C Weidner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Three new familial hemiplegic migraine mutants affect P/Q-type Ca2+ channel kinetics
RL Kraus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The global burden of disease study - Implications for neurology
M Menken et al.
ARCHIVES OF NEUROLOGY (2000)
分享论文
